Table 2 Causative variants only detected by the FJD-pipeline in the cancer and cardiovascular disease datasets as part of a systematic reanalysis of negative cases.

From: An evaluation of pipelines for DNA variant detection can guide a reanalysis protocol to increase the diagnostic ratio of genetic diseases

Panel

Sample

Gene

Transcript

Nucleotide

Type

Inheritance

zygosity

Phenoty

Region

ACMG

ACMG Criteria

GnomAD AF

TSCa

18-0744

RB1

NM_000321.2

c.1049 + 3 A > G

SNV

AD

HET

Retinoblastoma

Splicing

Likely Pathogenic

PM2, PP3, PP5

-

18-0871

NF1

NM_001042492.2

c.7190-2 A > C

SNV

AD

HET

Neurofibromatosis type 1

Splicing

Pathogenic

PVS1, PM2,PP3

-

NRC

18-0910

MYBPC3

NM_000256.3

c.1928-2 A > G

SNV

AD

HET

Arrhythmmia Disorder

Splicing

Pathogenic

PVS1, PP5, PM2,PP3

-

18-2249

KCNH2

NM_000238.4

c.1557 + 1 G > C

SNV

AD

HET

Hypertrophic cariomyopathy

Splicing

Pathogenic

PVS1, PP5, PM2, PP3

-